Advance Capital Management’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29,686
Closed -$1.29M 200
2026
Q1
$1.29M Sell
29,686
-3,555
-11% -$157K 0.05% 53
2025
Q4
$1.47M Sell
33,241
-680
-2% -$29.8K 0.06% 51
2025
Q3
$1.47M Sell
33,921
-583,337
-95% -$24.6M 0.06% 48
2025
Q2
$25.3M Sell
617,258
-67,614
-10% -$2.64M 1.15% 12
2025
Q1
$26.3M Buy
684,872
+256,649
+60% +$10.1M 1.26% 11
2024
Q4
$16.9M Buy
+428,223
New +$16.9M 0.77% 12

Other funds holding DOCT

Advance Capital Management's DOCT Position: Q2 2026 in Review

Advance Capital Management sold out of FT Vest US Equity Deep Buffer ETF October (DOCT) in Q2 2026, closing a stake of 29,686 shares — an estimated $1.29M sold.

Advance Capital Management first reported a position in DOCT in Q4 2024 and held it in 6 quarters. The position peaked at $26.3M in Q1 2025. 107 funds tracked by Wall St. Rank hold DOCT as of Q2 2026.

  • Advance Capital Management reported no remaining FT Vest US Equity Deep Buffer ETF October position as of Q2 2026 after selling out during the quarter.
  • Advance Capital Management sold 29,686 FT Vest US Equity Deep Buffer ETF October shares in Q2 2026, an estimated $1.29M.
  • Advance Capital Management first reported a position in FT Vest US Equity Deep Buffer ETF October in Q4 2024 and held it in 6 quarters.
  • Advance Capital Management's FT Vest US Equity Deep Buffer ETF October position peaked at $26.3M in Q1 2025.
  • 107 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q2 2026.

Based on Advance Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.